SecBot SecBot

NXPL

NextPlat Corp
Nasdaq· Telephone Communications (No Radiotelephone)· Inc. NV· CIK 0001058307 Media & Telecom
$8.66 +0.20 (+2.36%)
Oct 27 4:00 PM ET · prev $8.46
Market cap
$23.1M
Nano cap
Median target
$12.00
+39% · range $12.00–12.00
Next earnings
Nov 16
in 20 days · EPS est. −$0.46
1 year
+9.6%
from $7.90 · Oct 27
30 days
−5.9%
from $9.20
52-week range
$3.70–9.80
−12% from high · low Mar 31
Avg volume 20D
15.1K
Oct 23 spike 43.8K
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
Filing reports
3
analyzed by SecBot
SecBot read BULLISH 5 reports · 90 days
Balance 0 bearish · 2 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/5 ·Next Earnings date, Nov 16, 2026
Strongest BULLISH NextPlat Corp completed the acquisition of an independent pharmacy near Pensacola, Florida for $1,485,439 in…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • TrendDOWNTREND

    4% below its 50-day average.

Who's buying

13F
Top holderSharesValue
GEODE CAPITAL MANAGEMENT, LLC21,992$148.5K
VANGUARD CAPITAL MANAGEMENT LLC21,422$144.6K
CITADEL ADVISORS LLC18,582$125.4K
VANGUARD FIDUCIARY TRUST CO9,056$61.1K
Vanguard Global Advisers, LLC264$1.8K
UBS Group AG1$7.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jun 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +39%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Jun 24, 2026Litchfield Hills
INITIATE
INITIATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 16, 2026
Earnings date
NXPL Q3 2026 Earnings Scheduled — 2026-11-16
Recent
Oct 22, 2026
Press release
NextPlat's PharmcoRx to Launch Automated Point-of-Care Prescription Dispensing Supporting Improved Patient Adherence and Pharmacy Growth
VendRx kiosks could expand PharmcoRx's reach through clinic partnerships, creating new, scalable opportunities for incremental prescription volumes…
Oct 13, 2026
Contract
NextPlat Opens New Jacksonville Pharmacy Location to Offer High-Value Services for Patients and Local Healthcare Providers
New Jacksonville location expands PharmcoRx's statewide network with contracted services for 340B providers, long-term care facilities and specialty…
Oct 6, 2026
M&A
NextPlat Completes Pensacola-Area Acquisition of Profitable Pharmacy, Accelerating Continued Healthcare Growth and Profitability
Strategic Acquisition Enhances Pharmacy Diversification into Underserved Market, Supporting the Launch of New High-Value, High Margin Healthcare…
Aug 13, 2026
Earnings
NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40%
Growth Momentum Continues Across the Business, Highlighted by Increased Higher-Margin 340B Healthcare Prescription Volumes and Over 27% Sequential…
Aug 13, 2026
Earnings date
NXPL Q2 2026 Earnings Scheduled — 2026-08-13

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 14, 2026
Phipps David
Chief Executive Officer
AWARD6,000 sh
Oct 14, 2026
Ferrio Amanda
Chief Financial Officer
AWARD3,000 sh
Oct 14, 2026
Bedwell Robert Phillip Jr.
Chief Compliance Officer
AWARD1,250 sh
Sep 30, 2026
Armas Anthony
Director
AWARD661 sh
Sep 30, 2026
Barreto Rodney
Director
AWARD1,323 sh
Sep 30, 2026
ELLENOFF DOUGLAS
Director
AWARD1,323 sh
Jun 30, 2026
Armas Anthony
Director
AWARD943 sh
Jun 30, 2026
Barreto Rodney
Director
AWARD1,886 sh

Earnings setup

Estimates
Nov 16
reports in 20 days
−$0.46
EPS estimate, this quarter
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.46-$0.46–-$0.46—$13.0M
Next Q$0.07$0.07–$0.07+0.0%$15.0M
Current FY-$0.85-$0.85–-$0.85-54.5%$49.7M
Next FY$0.61$0.61–$0.61+5.2%$73.0M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 Other
NextPlat's PharmcoRx to Launch Automated Point-of-Care Prescription Dispensing Supporting Improved Patient Adherence and Pharmacy Growth
VendRx kiosks could expand PharmcoRx's reach through clinic partnerships, creating new, scalable opp
Oct 14, 2026 Insider
Phipps David was granted 6,000 shares
Chief Executive Officer
Oct 14, 2026 Insider
Ferrio Amanda was granted 3,000 shares
Chief Financial Officer
Oct 14, 2026 Insider
Bedwell Robert Phillip Jr. was granted 1,250 shares
Chief Compliance Officer
Oct 13, 2026 Press
NextPlat Corp opened a new PharmcoRx community pharmacy in Jacksonville, Florida, expanding its statewide network to…
Impact 3/10
Oct 6, 2026 SEC
NextPlat Corp completed the acquisition of an independent pharmacy near Pensacola, Florida for $1,485,439 in cash. The…
8-K — Impact 5/10
Oct 6, 2026 Press
NextPlat Corp. completed the acquisition of an independent pharmacy near Pensacola, Florida for $1.485 million in…
Impact 5/10
Aug 13, 2026 SEC
NextPlat reported Q2 2026 revenue of $11.9M, slightly above the $11.0M consensus, but EPS of -$0.42 missed the -$0.21…
PRESS-RELEASE — Impact 6/10

SecBot reports

3 filings · 2 press releases · 1 bullish · 0 bearish · 1 mixed · 1 neutral
All NXPL filing & press-release reports (5)